You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Protein Kinase Inhibitors

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

Not yet recruiting
  • B-cell Lymphoma
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Aug 9, 2022

Protein Kinase A in Prostate Cancer Tissue.

Not yet recruiting
  • Prostate Neoplasm
  • +2 more
  • prostate biopsy
  • (no location specified)
Jul 14, 2022

Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Abrocitinib 200 MG Oral Tablet
  • +2 more
  • (no location specified)
Feb 21, 2023

Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Rotterdam, Netherlands
      Erasmus MC
    Feb 2, 2022

    Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

    Recruiting
    • Olverembatinib
    • +2 more
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Jul 26, 2022

    Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

    Recruiting
    • Lung Neoplasms
    • +23 more
    • La Jolla, California
    • +35 more
    Oct 6, 2022

    Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial (BGB-11417)

    Not yet recruiting
    • Leukemia
    • +4 more
    • (no location specified)
    Jul 27, 2022

    Neurofibromatosis 1, Neurofibroma Plexiform Trial in Shanghai (Selumetinib)

    Active, not recruiting
    • Neurofibromatosis 1
    • Neurofibroma Plexiform
    • Shanghai, China
    • +1 more
    Jan 13, 2023

    Tyrosine Kinase Inhibitors in Trastuzumab Emtansine Resistant

    Recruiting
    • Breast Cancer
    • Nanjing, Jiangsu, China
      Jiangsu Provincial People's Hospital
    Feb 7, 2022

    Kidney Tumor Trial in France (blood sampling for ITK dosage)

    Recruiting
    • Kidney Neoplasm
    • blood sampling for ITK dosage
    • Marseille, France
    • +4 more
    Jan 6, 2023

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Biospecimen Collection
    • +4 more
    • Birmingham, Alabama
    • +170 more
    Jan 30, 2023

    Solid Tumor, Unspecified, Adult Trial in Meldola (68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission

    Recruiting
    • Solid Tumor, Unspecified, Adult
    • 68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission tomography / Computerized tomography
    • Meldola, Forlì Cesena, Italy
      IRCCS Istituto ROmagnolo per lo Studio dei Tumori "Dino Amadori"
    Nov 15, 2023

    Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    Aug 9, 2022

    free Survival and Evaluate Participant Experience for Metastatic

    Active, not recruiting
    • Anaplastic Lymphoma Kinase-positive
    • Carcinoma Non-small-cell Lung
    • Maynard, Massachusetts
      EmpiraMed, Inc.
    Feb 28, 2022

    Acute Kidney Injury, Extracorporeal Circulation; Complications, Surgery Trial in Wuhan (PKN1 level)

    Completed
    • Acute Kidney Injury
    • +2 more
    • PKN1 level
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    May 19, 2022

    Cervical Cancer, Cervical Carcinoma Trial in Guangzhou (Zimberelimab, Lenvatinib)

    Not yet recruiting
    • Cervical Cancer
    • Cervical Carcinoma
    • Guangzhou, China
      Sun Yat-sen University Cancer Cetntre
    Apr 9, 2023

    The Life After Stopping Tyrosine Kinase Inhibitors Study

    Completed
    • Leukemia, Myeloid, Chronic
    • Imatinib (Stopping their TKI)
    • +3 more
    • San Francisco, California
    • +15 more
    Jan 3, 2023

    Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

    Recruiting
    • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2023

    Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

    Not yet recruiting
    • Lung Cancer
    • Non Small Cell Lung Cancer
    • Amivantamab 1050mg
    • +2 more
    • Aurora, Colorado
    • +2 more
    Apr 25, 2023

    Hemophilia B With Inhibitor, Hemophilia B Trial (SerpinPC)

    Not yet recruiting
    • Hemophilia B With Inhibitor
    • Hemophilia B
    • (no location specified)
    Mar 16, 2023

    Cold-water Immersion, Protein-carbohydrates Supplementation, Active Recovery Trial in Puerto Real (Cold-water immersion,

    Completed
    • Cold-water Immersion
    • +3 more
    • Cold-water immersion
    • +3 more
    • Puerto Real, Cadiz, Spain
      Science of Education Faculty
    Mar 27, 2023

    Melanoma (Skin) Trial in Dijon, Thionville, Vandœuvre-lès-Nancy (Blood sampling)

    Active, not recruiting
    • Melanoma (Skin)
    • Blood sampling
    • Dijon, France
    • +3 more
    Mar 29, 2022

    Carcinoma, Adenoid Cystic Trial in Qingdao (EGFR-TK Inhibitor)

    Recruiting
    • Carcinoma, Adenoid Cystic
    • EGFR-TK Inhibitor
    • Qingdao, Shandong, China
      Qingdao central Hospital
    Nov 1, 2021

    NSCLC With EGFR Mutation Trial in Mexico City (Glutamine plus L. reuteri)

    Recruiting
    • Non-Small Cell Lung Cancer With EGFR Mutation
    • Glutamine plus L. reuteri
    • Mexico City, Mexico
      Instituto Nacional de Cancerologia de Mexico
    May 2, 2023

    NSCLC Stage IIIB~IV Trial in Taipei (Atezolizumab Injection; bevacizumab Injection)

    Recruiting
    • NSCLC Stage IIIB~IV
    • Atezolizumab Injection; bevacizumab Injection
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jan 18, 2022